0001567619-21-004128.txt : 20210216 0001567619-21-004128.hdr.sgml : 20210216 20210216190041 ACCESSION NUMBER: 0001567619-21-004128 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210215 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dobson Mitchell D CENTRAL INDEX KEY: 0001756677 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 21641808 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2021-02-15 0 0000722723 HANGER, INC. HNGR 0001756677 Dobson Mitchell D 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 0 1 0 0 SVP, Chief Compliance Officer Common Stock 2021-02-15 4 A 0 3583 0 A 32360 D Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2020 and ending on December 31, 2020. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date. Consists of (i) unvested restricted shares totaling 3,583 shares of stock from an initial grant of 3,583 shares of restricted stock that begins to vest on March 9, 2021; (ii) unvested restricted shares totaling 4,215 shares of stock from an initial grant of 4,215 shares of restricted stock that begins to vest on March 9, 2021; (iii) unvested restricted shares and fully vested shares totaling 3,619 shares of stock from an initial grant of 3,854 shares of restricted stock made on March 8, 2019 (iv) unvested restricted shares and fully vested shares totaling 4,289 shares of stock from an initial grant of 4,567 shares of restricted stock made on March 8, 2019; [continued in next footnote] (v) unvested restricted shares and fully vested shares totaling 4,209 shares of stock from an initial grant of 5,000 shares of restricted stock made on March 9, 2018; (vi) unvested restricted shares and fully vested shares totaling 3,774 shares of stock from an initial grant of 5,000 shares of restricted stock made on March 8, 2017; (vii) unvested restricted shares and fully vested shares totaling 2,667 shares of stock from an initial grant of 4,150 shares of restricted stock made on April 29, 2016; [continued in next footnote] (viii) fully vested shares totaling 1,247 shares of stock from an initial grant of 1,653 shares of restricted stock made on November 10, 2015; (ix) fully vested shares totaling 119 shares of stock from an initial grant of 200 shares of restricted stock made on March 6, 2015; (x) fully vested shares totaling 2,179 shares of stock from an initial grant of 3,604 shares of restricted stock made on March 6, 2015; (xi) fully vested shares totaling 990 shares of stock from an initial grant of 1,598 shares of restricted stock made on March 7, 2014; (xii) fully vested shares totaling 827 shares of stock from an initial grant of 1,800 shares of restricted stock made on March 11, 2013; (xiii) fully vested shares totaling 428 shares from an initial grant of 1,400 shares of restricted stock made on March 7, 2012; [continued in next footnote] and (xiv) fully vested shares totaling 214 shares from an initial grant of 1,400 shares of restricted stock made on March 25, 2011. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Mitchell D. Dobson 2021-02-16